Trial · NCT02173379
Results by group354
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 354
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Target Lesion Failure (TLF) | Absorb BVS | 64 | Participants | ||
| Number of Participants With Target Lesion Failure (TLF) | XIENCE | 48 | Participants | ||
| TLF at 1-year, Non-inferiority Against the Control | Absorb BVS | 98 | Participants | ||
| TLF at 1-year, Non-inferiority Against the Control | XIENCE | 82 | Participants | ||
| Angina at 1-year, Non-inferiority Against the Control | Absorb BVS | 459 | Participants | ||
| Angina at 1-year, Non-inferiority Against the Control | XIENCE | 494 | Participants | ||
| Percentage of Target Lesion With Acute Success- Device Success (Lesion Level Analysis) | Absorb BVS | 94.6 | Percentage of target lesions | ||
| Percentage of Target Lesion With Acute Success- Device Success (Lesion Level Analysis) | XIENCE | 99.0 | Percentage of target lesions | ||
| Number of Participants With Acute Success- Procedural Success (Subject Level Analysis) | Absorb BVS | 1194 | Participants | ||
| Number of Participants With Acute Success- Procedural Success (Subject Level Analysis) | XIENCE | 1246 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | Absorb BVS | 1 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | XIENCE | 0 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | Absorb BVS | 1 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | XIENCE | 1 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | Absorb BVS | 5 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | XIENCE | 5 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | Absorb BVS | 7 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | XIENCE | 8 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | Absorb BVS | 10 | Participants | ||
| Number of Death (Cardiac, Vascular, Non-cardiovascular) | XIENCE | 11 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02173379/results